Skip to main content
. 2013 Nov 20;77(6):1027–1038. doi: 10.1111/bcp.12291

Table 3.

Association between pharmacokinetic parameters and pharmacological effect of nefopam analysed by logistic regression

Logistic regression Overall correct percentage of prediction* Receiver operating curve analysis
Model acceptance Goodness of fit OR and adjusted OR
Predictors Unit increment Final −2 log likelihood P value of OTMC Nagelkerke r2 Hosmer–Lemeshow test Wald test Exp (B) Lower 95% CI Upper 95% CI Area under curves P value Cut value* Final model status
Tachycardia AUCnef0→∞ 1 μg l−1 h 26.390 0.128 0.250 0.867 0.049 1.001 1.000 1.002 80% 0.788 0.019 3280 μg l−1 h
Cmaxnef 1 μg l−1 24.338 0.05 0.330 0.770 0.025 1.010 1.003 1.018 83% 0.887 0.002 389 μg l−1 Appropriate
50 μg l−1 0.025 1.580 1.060 2.355 Appropriate
RCmaxnef 1 μg l−1 h−1 24.058 0.046 0.341 0.755 0.023 1.005 1.001 1.009 83% 0.892 0.001 764 μg l−1 h−1 Appropriate
50 μg l−1 h−1 0.023 1.261 1.033 1.538 Appropriate
PONV AUCnef0→∞ 1 μg l−1 h 28.742 0.079 0.328 0.550 0.021 1.002 1.000 1.003 82.4% 0.726 0.056 3280 μg l−1 h
Cmaxnef 1 μg l−1 23.335 0.008 0.501 0.829 0.012 1.014 1.003 1.026 85.3% 0.774 0.021 437.44 μg l−1 Appropriate
50 μg l−1 0.012 2.053 1.169 3.605 Appropriate
RCmaxnef 1 μg l−1 h−1 23.482 0.009 0.497 0.882 0.012 1.007 1.002 1.012 85.3% 0.744 0.21 859 μg l−1 h−1 Appropriate
50 μg l−1 h−1 0.012 1.416 1.078 1.859 Appropriate
Morphine requirement AUCnef0→∞ 1 μg l−1 h 41.468 0.006 0.253 0.350 0.023 0.988 0.987 1.000 68% 0.745 0.013 947 μg l−1 h Appropriate
Cmaxnef 1 μg l−1 41.797 0.007 0.243 0.349 0.048 0.988 0.977 1.000 68% 0.724 0.024 79 μg l−1 Appropriate
RCmaxnef 1 μg l−1 h−1 41.567 0.006 0.250 0.353 0.047 0.994 0.988 1.000 68% 0.730 0.020 154 μg l−1 h−1 Appropriate

Abbreviations are as follows: AUCnef0→∞, Area Under Curve of time course of nefopam plasma concentration; Cmaxnef, nefopam plasma maximum concentration; CI, confidence interval; OR, odds ratio; OTMC, omnibus test of model coefficients; PONV, postoperative nausea and vomiting; RCmax, rate of increase of plasma concentration.

*

The cut value corresponds to the predicted probability of the model higher than 0.60 for tachycardia, 0.80 for PONV and 0.50 for morphine requirement.

Null hypothesis/true area = 0.5.

Adjusted for confounding covariates (see the results of the pharmacodynamics assessment); AUCnef0→∞, Cmaxnef and RCmaxnef were ranged, respectively, within 382.5–3620 μg l−1 h, 19.2–512.8 μg l−1 and 37.7–1037 μg l−1 h−1.